Dendrimers in gene delivery

Christine Dufès, Ijeoma F. Uchegbu, Andreas G. Schätzlein

Research output: Contribution to journalArticle

  • 735 Citations

Abstract

Dendrimers have unique molecular architectures and properties that make them attractive materials for the development of nanomedicines. Key properties such as defined architecture and a high ratio of multivalent surface moieties to molecular volume also make these nanoscaled materials highly interesting for the development of synthetic (non-viral) vectors for therapeutic nucleic acids. Rational development of such vectors requires the link to be made between dendrimer structure and the morphology and physicochemistry of the respective nucleic acid complexes and, furthermore, to the biological performance of these systems at the cellular and systemic level. The review focuses on the current understanding of the role of dendrimers in those aspects of synthetic vector development. Dendrimer-based transfection agents have become routine tools for many molecular and cell biologists but therapeutic delivery of nucleic acids remains a challenge.
LanguageEnglish
Pages2177-2202
Number of pages25
JournalAdvanced Drug Delivery Reviews
Volume57
Issue number15
DOIs
StatePublished - 2005

Fingerprint

Dendrimers
Nucleic Acids
Genes
Nanomedicine
Transfection
Therapeutics

Keywords

  • microparticle
  • branched polymer
  • dendrimer
  • dendritic structure
  • pharmaceutical technology
  • DNA
  • nanoparticle
  • genetic transfer
  • gene therapy

Cite this

Dufès, C., Uchegbu, I. F., & Schätzlein, A. G. (2005). Dendrimers in gene delivery. Advanced Drug Delivery Reviews, 57(15), 2177-2202. DOI: 10.1016/j.addr.2005.09.017
Dufès, Christine ; Uchegbu, Ijeoma F. ; Schätzlein, Andreas G./ Dendrimers in gene delivery. In: Advanced Drug Delivery Reviews. 2005 ; Vol. 57, No. 15. pp. 2177-2202
@article{e00f3e68941a4c3db622a8aa98b9d1d8,
title = "Dendrimers in gene delivery",
abstract = "Dendrimers have unique molecular architectures and properties that make them attractive materials for the development of nanomedicines. Key properties such as defined architecture and a high ratio of multivalent surface moieties to molecular volume also make these nanoscaled materials highly interesting for the development of synthetic (non-viral) vectors for therapeutic nucleic acids. Rational development of such vectors requires the link to be made between dendrimer structure and the morphology and physicochemistry of the respective nucleic acid complexes and, furthermore, to the biological performance of these systems at the cellular and systemic level. The review focuses on the current understanding of the role of dendrimers in those aspects of synthetic vector development. Dendrimer-based transfection agents have become routine tools for many molecular and cell biologists but therapeutic delivery of nucleic acids remains a challenge.",
keywords = "microparticle, branched polymer, dendrimer, dendritic structure, pharmaceutical technology, DNA, nanoparticle, genetic transfer, gene therapy",
author = "Christine Duf{\`e}s and Uchegbu, {Ijeoma F.} and Sch{\"a}tzlein, {Andreas G.}",
year = "2005",
doi = "10.1016/j.addr.2005.09.017",
language = "English",
volume = "57",
pages = "2177--2202",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
number = "15",

}

Dufès, C, Uchegbu, IF & Schätzlein, AG 2005, 'Dendrimers in gene delivery' Advanced Drug Delivery Reviews, vol. 57, no. 15, pp. 2177-2202. DOI: 10.1016/j.addr.2005.09.017

Dendrimers in gene delivery. / Dufès, Christine; Uchegbu, Ijeoma F.; Schätzlein, Andreas G.

In: Advanced Drug Delivery Reviews, Vol. 57, No. 15, 2005, p. 2177-2202.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dendrimers in gene delivery

AU - Dufès,Christine

AU - Uchegbu,Ijeoma F.

AU - Schätzlein,Andreas G.

PY - 2005

Y1 - 2005

N2 - Dendrimers have unique molecular architectures and properties that make them attractive materials for the development of nanomedicines. Key properties such as defined architecture and a high ratio of multivalent surface moieties to molecular volume also make these nanoscaled materials highly interesting for the development of synthetic (non-viral) vectors for therapeutic nucleic acids. Rational development of such vectors requires the link to be made between dendrimer structure and the morphology and physicochemistry of the respective nucleic acid complexes and, furthermore, to the biological performance of these systems at the cellular and systemic level. The review focuses on the current understanding of the role of dendrimers in those aspects of synthetic vector development. Dendrimer-based transfection agents have become routine tools for many molecular and cell biologists but therapeutic delivery of nucleic acids remains a challenge.

AB - Dendrimers have unique molecular architectures and properties that make them attractive materials for the development of nanomedicines. Key properties such as defined architecture and a high ratio of multivalent surface moieties to molecular volume also make these nanoscaled materials highly interesting for the development of synthetic (non-viral) vectors for therapeutic nucleic acids. Rational development of such vectors requires the link to be made between dendrimer structure and the morphology and physicochemistry of the respective nucleic acid complexes and, furthermore, to the biological performance of these systems at the cellular and systemic level. The review focuses on the current understanding of the role of dendrimers in those aspects of synthetic vector development. Dendrimer-based transfection agents have become routine tools for many molecular and cell biologists but therapeutic delivery of nucleic acids remains a challenge.

KW - microparticle

KW - branched polymer

KW - dendrimer

KW - dendritic structure

KW - pharmaceutical technology

KW - DNA

KW - nanoparticle

KW - genetic transfer

KW - gene therapy

U2 - 10.1016/j.addr.2005.09.017

DO - 10.1016/j.addr.2005.09.017

M3 - Article

VL - 57

SP - 2177

EP - 2202

JO - Advanced Drug Delivery Reviews

T2 - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 15

ER -

Dufès C, Uchegbu IF, Schätzlein AG. Dendrimers in gene delivery. Advanced Drug Delivery Reviews. 2005;57(15):2177-2202. Available from, DOI: 10.1016/j.addr.2005.09.017